Abstract
Pain is a peculiar function with many psychic, neural and endocrine aspects. It is the most common reason for patients to come to a doctor, and in spite of the rapidly expanding possibilities of causal therapy, symptomatic pain relief has still remained one of the main tasks of medical practice. In addition, as a result of rapid drug development, the majority of drugs prescribed, especially those for causal therapy, have been produced in the last two decades, while the analgetics most widely used like morphine, codeine, acetylsalicylic acid, aminopyrine, phen-acetin were all developed before this century. Unfortunately, these analgetics do not owe their steady use to some ideal properties but to the mere fact that none of the many products of a world-wide intensive research has met better the requirements of the “ideal agent”. An ideal agent would be effective against either mild or severe pain, it would be free from respiratory depressant and other side effects and it would be non-addicting. Of the drugs used neither the so-called “major” nor the “minor” analgetics fulfil these criteria. The minor, or antipyretic analgetics are effective only against mild pain and evoke serious side effects. Because of the danger of bone-marrow depression and agranulocytosis aminopyrine is not used anymore in many countries. There is a world-wide tendency to withdraw phenacetin, too, since it damages haemoglobin in the circulating erythrocytes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bognár, R. and Makleit, S. (1968): Conversions of tosyl and niesyl derivatives of th morphine group. Aminoniorphides and aminocodides. Acta chim. Acad. Sci. hung.58, 203–205.
Bognár, R., Makleit, S. and Mile, T. (1969a): Conversions of tosyl and mesyl derivatives of the morphine group. Synthesis of acetylmercapto and mercapto derivatives. Acta chim. Acad. Sci. hung.59, 161–164.
Bognár, R., Makleit, S. and Mile, T. (1969b): Conversions of tosyl and mesyl derivatives of the morphine group. Preparation of “azido- and aminomorphides”. Acta chim. Acad. Sci. hung.59, 379–385.
Buckett, W. R. (1964): A new test for morphine-like physical dependence (addiction liability) in rats. Psychopharmacologia6, 410–416.
Ettles, M. and Lister, R. E. 1963. cit. by Buckett (1964): The assessment of withdrawal symptom in narcotic dependent rats. Communication to the British Pharmacological Society. Dublin 1963.
Fürst, S. and Knoll, J. (1968): Újabb adatok a morfintolerancia kérdéséhez (Recent data to the question of morphine tolerance). Herba Hung.7, 53.
Fürst, S. and Knoll, J. (1970): Homopyrimidazols and tolerance to narcotic analgetics. In: 7th Congress of the Collegium Internationale Neuropsychopharmacologicum. Abstracts, Prague, p. 145.
Fürst, S. and Knoll, J. (1971): A new approach to dependence and tolerance. Pharmacology of azidomorphine derivatives. Acta physiol. Acad. Sci. hung. (In press).
Fürst, S., Szentmiklósi, P., Kelemen, K. and Knoll, J. (1969): A detailed analysis of the analgetic action of MZ-108, a new homopyrimidazol derivative. In: 5th Hungarian Conference for Therapy and Pharmacological Research. Budapest. Abstracts, p. 83.
Fürst, S., Mészáros, Z. and Knoll, J. (1970): Pharmacology of MZ-144, new homopyrimidazol derivative. Acta physiol. Acad. Sci. hung.37, 189.
Fürst, S., Kelemen, K. and Knoll, J. (1971): Comparative pharmacology of azidomorphine derivatives. Acta physiol. Acad. Sci. hung. (In press.)
Graber, H. and Varga, E.: The effect of MZ-144 (Probon®) on the respiratory acidosis of aged patients. Clin. Pharmacol. Ther. (In press.)
Graber, H., Szentmiklösi, P. and Krepuska, J.: Clinical evaluation of the analgetic action of Probon® Clin. Pharmacol. Titer. (In press.)
Kelemen, K. (1968): Új szempontok az analgetikus morfin antagonistâk farmako-lógiájában (Recent aspects in the pharmacology of analgetic morphine antagonists). Orvostudomdny19, 369–374.
Knoll, J. (1969): Homopyrimidazols, a new group of analgesics. In: 5th Hungarian Conference for Therapy and Pharmacological Besearch. Budapest, Abstracts. 1968.
Knoll, J., Mészábos, Z. and Fübst, S. (1969): Homopyrimidazols, a new group of analgesics, with unique spectrum of activity. In: 4th International Congress of Pharmacology, Basel, Abstracts, p. 455.
Knoll, J., Fübst, S. and Meszabos, Z. (1971a): The pharmacology of 1,6-dimethyl-3-carbetoxy-4-oxo-6,7,8,9-tetrahydohoniopyriniidazol-niethylsulphate (MZ-144), a new potent, non-narcotic analgesic. Toxicity and analgesic effect of MZ-144 compared to narcotic and non-narcotic analgesics. Arzneimittel Forsch.21, 719–727.
Knoll, J., Fübst, S. and Mészàbos, Z. (1971b): The pharmacology of 1,6-dimethyl-3-carbetoxy-4-oxo-6,7,8,9-tetrahydrohomopyrimidazol-methylsulphate (MZ-144), a new potent, non-narcotic analgesic. Analysis of the central and peripheric effects. Arzneimittel Forsch. 29, 727–733.
Knoll, J., Magyab, K. and Bánfi, D. (1971c): The pharmacology of 1,6-dimethyl-3-carbetoxy-4-oxo-6,7,8,9-tetrahydrohomopyrimidazol-methylsulphate (MZ-144), a new potent, non-narcotic analgesic. The fate of MZ-144 within the organism. Arzneimittel Forsch.21, 733–738.
Knoll, J., Mészábos, Z., Szentmiklosi, P. and Fübst, S. (1971d): The pharmacology of 1,6-dimethyl-3-carbetoxy-4-oxo-6,7,8,9-tetrahydrohomopyrimidazol-methylsul-phate (MZ-144), a new potent, non-narcotic analgesic. Some basic correlations between the chemical structure and activity of homopyrimidazol analgesics. Selection of MZ-144. Arzneimittel Forsch.21, 717–719.
Lewis, J. W., Bentley, K. W. and Cowan, A. (1971): Narcotic analgesics and antagonists. Ann. Rev. Pharmacol.11, 241–270.
Makleit, S. and Bognab, R. (1968): Amino-morfidok és amino-kodidok előállitásá-nak és térkémiájának vizsgálatarol (Study of the production and stereochemistry of amine morphides and amine codides). Kémiai Közl.30, 289–295.
Makleit, S. and Bognáb, R. (1969): Conversions of tosyl and mesyl derivatives of the morphine group. A new method for the preparation of isocodeine and dihydro-isocodeine. Acta chim. Acad. Sci. hung.59, 387–388.
Report of WHO Scientific Group (1964): Wld Hlth Org. techn. Rep. Ser. 273.
Schaumann, O. (1956): Some new aspects of the action of morphine-like analgesics. Brit. med. J.2, 1091–1093.
Seevebs, M. H. and Deneatj, G. A. (1963): Physiological aspects of tolerance and physical dependence. In: Physiological Pharmacology. Vol. 1. Ed. by W. S. Root and H. Hofmann. Academic Press, New York. pp. 565–640.
Selley, C. and Eckhardt, S.: Clinical study of the morphine-potentiating effect of MZ-144 in oncologic patients. (In press.)
deStevens, G. (Ed.) (1965): Analgetics. Academic Press, New York. pp. 475.
Ungab, G. and Cohen, M. (1966): Induction of morphine tolerance by material extracted from brain of tolerant animals. Int. J. Neuropharmacol.5, 183–192.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1973 Akadémiai Kiadó, Budapest, Hungary
About this chapter
Cite this chapter
Kelemen, K. (1973). Analgesia, Tolerance and Drug Dependence. In: Lissák, K. (eds) Hormones and Brain Function. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2007-4_28
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2007-4_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2009-8
Online ISBN: 978-1-4684-2007-4
eBook Packages: Springer Book Archive